Health diagnostics - PowerPoint PPT Presentation


Biomarker and Companion Diagnostics Event-20th - 21st June 2024 -Boston, USA

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/2nd-annual-

4 views • 5 slides


Technological Advancements in Molecular Diagnostics is Driving the Growth of this Market

North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User

0 views • 3 slides



Increasing Focus on Companion Diagnostics Creates an Opportunity for the Europe

Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)

0 views • 3 slides


Asia-Pacific Molecular Diagnostics Market

Asia-Pacific Molecular Diagnostics Market\nAsia-Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments) Test Type (Lab, PoC) Technology (PCR, ISH, Sequencing, INAAT, Microarray) Application (Infectious Diseases, Oncology) End User (Hospitals, Diagnostic Lab)

0 views • 3 slides


Latin America Molecular Diagnostics Market

Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User

0 views • 3 slides


South East Asia Molecular Diagnostics Market

Meticulous Research\u00ae\u2014a leading market research company, published a research report titled, \u2018South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Infl

0 views • 3 slides


Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference

Introduction:\nIn the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th October 2024. \n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/european-medical-devices-and-dia

2 views • 5 slides


Enhancing Diagnostics Programme for Improved Healthcare in Cheshire and Merseyside

Diagnostics are crucial for prevention, monitoring, and improving patient outcomes. The programme in Cheshire and Merseyside aims to provide equitable, efficient, and innovative diagnostic services to enhance the overall health and well-being of the community. It covers a wide range of tests and foc

0 views • 17 slides


Biomarker and Companion Diagnostics Conference -USA (20th - 21st June 2024)

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nBecome a Speaker @ \/\/events.marketsandmarkets.com\/2nd-annual-b

1 views • 6 slides


Molecular Diagnostics Market_Blog

The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer.

0 views • 3 slides


Meticulous Research® Forecasts Middle East & Africa Molecular Diagnostics Market to Exceed $1.16 Billion

Middle East & Africa Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software) Test Type (Lab, PoC) Technology (PCR, ISH, INAAT, Sequencing, Microarray) Application (Influenza, HPV, Oncology, Gene Testing) End User

0 views • 2 slides


Europe Molecular Diagnostics Market Primed to Surpass $13.25 Billion by 2030

Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)

1 views • 2 slides


North America Molecular Diagnostics Market Projected to Reach $18.13 Billion by 2030

North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User

1 views • 2 slides


Advanced Instrumentation and Diagnostics for Superconducting Magnets at CERN

Explore the crucial needs for instrumentation and diagnostics at CERN, focusing on superconducting magnets. Topics include voltage and strain measurements, vibration analysis, temperature sensing, quench detection, and magnet form factor considerations. The importance of advanced diagnostics and com

1 views • 23 slides


Latin America Molecular Diagnostics Market Projected to Reach $2.50 Billion by 2031

Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User

0 views • 2 slides


South East Asia Molecular Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

Meticulous Research\u00ae\u2014a leading market research company, published a research report titled, \u2018South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Infl

3 views • 4 slides


Europe Cancer Diagnostics Market: Emerging Trends in Liquid Biopsy and Next-Gene

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides


Latin America Molecular Diagnostics Market - Opportunity Analysis

Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User - Forecast to 2031\n

3 views • 3 slides


Africa Molecular Diagnostics Market

Middle East & Africa Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software) Test Type (Lab, PoC) Technology (PCR, ISH, INAAT, Sequencing, Microarray) Application (Influenza, HPV, Oncology, Gene Testing) End User - Forecast to 2031

1 views • 5 slides


Molecular Diagnostics Market Projected to Reach $46.69 Billion by 2030

Molecular Diagnostics Market by Product (Reagent & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)

8 views • 2 slides


Global Digital Diagnostics Market Research Forecast & Analysis | BIS Research

The Global Digital diagnostics market is estimated to reach $8,319.2 million by 2033 from $1,431.7 million in 2023, growing at a CAGR of 19.24% during the forecast 2023-2033.

9 views • 3 slides


Asia-Pacific Livestock Diagnostics Market

Asia-Pacific Livestock Diagnostics Market by Product (Consumables {Swine Fever, Influenza}, System, Software), Technology (Immunodiagnostics {ELISA, LFA}, PCR), Animal Type (Swine, Bovine, Poultry), End User (POC, Veterinary Hospital) - Forecast to 2030

1 views • 4 slides


Comprehensive Report on Latin America Molecular Diagnostics Market Forecast to 2031 - Meticulous Research

Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User - Forecast to 2031\n

0 views • 3 slides


North America Molecular Diagnostics Market Projected to Reach $18.13 Billion by 2030

North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User

0 views • 2 slides


Meticulous Research Releases New Report - Molecular Diagnostics Market Expected to Hit $46.69 Billion by 2030

The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer.

0 views • 2 slides


Professional BMW Check Engine Light Service Accurate Diagnostics and Efficient Repairs for Reliable Driving

Professional BMW Check Engine Light Service provides precise diagnostics and efficient repairs to ensure your vehicle's optimal performance and reliability. Our expert technicians utilize advanced tools to identify and resolve issues promptly, minimizing downtime and restoring your BMW to peak condi

1 views • 32 slides


Global Digital Diagnostics Market: Transforming Healthcare Through Technology

According to BIS Research, the Global Digital Diagnostics Market is projected to reach $8,319.2 million by 2033 from $1,431.7 million in 2023, growing at a CAGR of 19.24% during the forecast period 2023-2033.

1 views • 3 slides


Biomarker and Companion Diagnostics Conference | (Boston) June 2024

MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edi

2 views • 6 slides


Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance

In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/european-medical-devic

1 views • 6 slides


Asia-Pacific Molecular Diagnostics Market Expected to Hit $11.87 Billion by 2030

\nMeticulous Research\u00ae\u2014a leading market research company, published a research report titled,\n \u2018Asia-Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments) Test Type\n (Lab, PoC) Technology (PCR, ISH, Sequencing, INAAT, Microarray) Application (Infectious \nDis

0 views • 3 slides


Europe Molecular Diagnostics Market is Projected to Reach $13.25 Billion by 2030

Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Forecast to 2030\n

0 views • 6 slides


Global Digital Diagnostics Market

The Global Digital Diagnostics Market Size is Anticipated to Exceed USD 7.60 Billion by 2033, Growing at a CAGR of 18.60% from 2023 to 2033.\n

0 views • 5 slides


Molecular Diagnostics in Asia-Pacific Poised for $11.87 Billion Market by 2030

Meticulous Research\u00ae\u2014a leading market research company, published a research report titled,\n \u2018Asia-Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments) Test Type\n (Lab, PoC) Technology (PCR, ISH, Sequencing,

0 views • 3 slides


National Free Diagnostics Initiative Overview

The National Free Diagnostics Initiative aims to provide essential diagnostic services free of cost in public health facilities, leveraging existing institutional structures. The initiative covers a range of pathological and radiological tests at different levels of care, with outsourcing for high-c

2 views • 20 slides


Enhancing Livestock Health Through Early Diagnostics and Targeted Antimicrobial Use

Utilizing early diagnostics in livestock for targeted antimicrobial administration is essential for effective disease management and reducing antimicrobial resistance. This approach aids in timely treatment, facilitates monitoring of animal health status, and supports preventive measures against eme

0 views • 10 slides


Helix Diagnostics: State-of-the-Art Clinical Laboratory in Michigan

Helix Diagnostics, founded in 2015 and located in Waterford Township, Michigan, is a cutting-edge clinical laboratory offering services such as therapeutic drug monitoring, blood chemistry testing, pharmacogenomics, and molecular pathogen detection. With over 125 employees, they serve a wide range o

0 views • 11 slides


Tuberculosis Diagnostics Market

The Tuberculosis Diagnostics Market is on track to achieve a value of $3.56 billion by 2031, fueled by a 5% CAGR from 2024. Explore the market's significant growth drivers and stay ahead of the curve by understanding future trends in TB diagnostics.\

0 views • 4 slides


GSI Contribution to CR Beam Diagnostics and Future Contracts

Contribution of GSI to CR beam diagnostics includes discussions on diagnostic devices, component status, working questions, and future contracts. Future plans involve the procurement of various devices and components required for beam diagnostics. Known demands for 400 mm diagnostics devices are out

0 views • 16 slides


Advanced Beam Diagnostics and Control Systems in Beam Physics

Cutting-edge detector technologies like KAPTURE and KALYPSO are revolutionizing beam diagnostics with ultra-fast Terahertz detectors and advanced line-camera systems. The POF III and POF IV projects focus on extreme beam control and diagnostics, aiming to probe femto-scale dynamics of relativistic p

0 views • 8 slides


Enhancing Tuberculosis Diagnostics Uptake in Kenya: Insights and Solutions

This study delves into the uptake of new tuberculosis diagnostics in Kenya, revealing challenges such as limited access and staffing issues. It highlights preferential coverage of certain diagnostic methods and identifies barriers to utilization, including health system challenges and low disease su

0 views • 10 slides